首页> 外文OA文献 >Design, Synthesis and Study of Novel Multivalent Ligands - Toward New Markers of Cancer Cells
【2h】

Design, Synthesis and Study of Novel Multivalent Ligands - Toward New Markers of Cancer Cells

机译:新型多价配体的设计,合成和研究-癌细胞新标记

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cancer is lacking early detection methods and treatment specificity. In order to increase the sensitivity and specificity towards cancer cells, we propose the use of multivalent interactions targeting specific receptor combinations at the cancer cell surface. In this thesis, we explored the design of multimers, which could provide such interactions. The design was investigated and revisited based on specific parameters, essential for the creation of multivalent interactions such as thermodynamics. The synthesis was designed so that libraries of homo- and hetero-multimers of different valencies can be obtained efficiently with good yields. The established synthetic scheme is empowered by its modularity, necessary to investigate different essential factors. Trimers composed of micromolar affinity MSH(4) targeting the MC1-R, overexpressed in melanoma, were investigated on a model cell line and resulted in the creation of nanomolar affinity constructs with up to 350 fold increase in affinity. Different multimers such as hexavalent and nonavalent dendrimers were synthesized and studied for their properties. All constructs had nanomolar affinity and showed to be non-toxic up to micromolar concentrations and imaging studies also confirmed their internalization, which overall demonstrate the potential for these compounds to be used as markers for cancer cells and as delivery agents. Trimers targeting the CCK2-R were similarly investigated for their potential as pancreatic cancer markers. However, those constructs did not seem to result in the expected enhancements in affinity, but the affinity of the initial monovalent agonist was in the 10-50 nanomolar range. As we were unable to design micromolar affinity agonist we investigated the use of antagonists. This study, revealed the importance of thermodynamics in the creation of multivalent interaction. Heterotrivalent ligands (CCK and MSH) were investigated for their potential in cross-linking different receptors and the study demonstrated the subtility to detect cross-linking. Finally, the different attempts toward the efficient synthesis of a tetra-orthogonal scaffold, a key feature needed to generate multimers that could target up to 3 different receptors was investigated and showed promising results. It is our hypothesis that such an approach will ultimately lead to specific markers of tumor cells, which could be used as diagnosis agents when modified with an imaging moiety and as a therapeutic agent when modified with a drug.
机译:癌症缺乏早期检测方法和治疗特异性。为了增加对癌细胞的敏感性和特异性,我们提出使用靶向癌细胞表面上特定受体组合的多价相互作用。在本文中,我们探索了可以提供这种相互作用的多聚体的设计。根据特定参数对设计进行了研究和重新审查,这对于创建多价相互作用(例如热力学)至关重要。对合成进行了设计,以便可以有效地以良好的收率获得不同价的同型和异型多聚体文库。已建立的综合方案具有模块化的能力,这是研究不同基本要素所必需的。在模型细胞系上研究了由针对黑色素瘤中过表达的MC1-R的微摩尔亲和力MSH(4)构成的三聚体,并导致创建了具有高达350倍亲和力的纳摩尔亲和力构建体。合成了不同的多聚体,例如六价和非价树状大分子,并对其性质进行了研究。所有构建体均具有纳摩尔摩尔亲和力,并且在微摩尔浓度下均显示无毒,并且成像研究也证实了其内在化,这总体证明了这些化合物用作癌细胞标记物和递送剂的潜力。类似地研究了靶向CCK2-R的三聚体作为胰腺癌标志物的潜力。然而,这些构建体似乎并未导致预期的亲和力增强,但是初始单价激动剂的亲和力在10-50纳摩尔范围内。由于我们无法设计微摩尔亲和力激动剂,因此我们研究了拮抗剂的使用。这项研究揭示了热力学在创建多价相互作用中的重要性。对异三价配体(CCK和MSH)在交联不同受体方面的潜力进行了研究,该研究证明了检测交联的潜能。最后,对有效合成四正交支架的不同尝试进行了研究,这是生成可靶向多达3种不同受体的多聚体所需的关键特征,并显示出令人鼓舞的结果。我们的假设是,这种方法最终会导致肿瘤细胞的特定标记,当用成像部分修饰时,可以用作诊断剂,而用药物修饰时,可以用作治疗剂。

著录项

  • 作者

    Brabez Nabila;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号